Literature DB >> 7937901

Enhanced tumor cell growth suppression by an N-terminal truncated retinoblastoma protein.

H J Xu1, K Xu, Y Zhou, J Li, W F Benedict, S X Hu.   

Abstract

The retinoblastoma (RB) gene encodes a nuclear phosphoprotein of 928 amino acids (pRB). Thus far, much effort in RB research has been focused on both the viral oncoprotein-binding domains and the C-terminal domain, whereas little is known about the N-terminal moiety of the protein. We report here that an N-terminal truncated RB protein of approximately 94 kDa (pRB94) exerts more potent cell growth suppression as compared to the full-length pRB protein in a diversity of tumor cell lines examined, including those having a normal endogenous RB gene. Tumor cells transfected with the pRB94-expressing plasmids displayed multiple morphological changes frequently associated with cellular senescence and/or apoptosis. They failed to enter S phase and rapidly died. The pRB94 expressed in recipient tumor cells had a longer half-life than the full-length pRB protein and tended to remain in an active un- or hypophosphorylated form. Since it has also been found that N-terminal truncated RB proteins often accumulated in growth-arrested and/or differentiated tumor cells, we suggest that N-terminal truncation of pRB may be one of the cellular mechanisms modulating the RB protein function in cell-cycle control.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7937901      PMCID: PMC44912          DOI: 10.1073/pnas.91.21.9837

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle.

Authors:  D W Goodrich; N P Wang; Y W Qian; E Y Lee; W H Lee
Journal:  Cell       Date:  1991-10-18       Impact factor: 41.582

2.  Expression of the human retinoblastoma gene product pp110RB in insect cells using the baculovirus system.

Authors:  N P Wang; Y W Qian; A E Chung; W H Lee; E Y Lee
Journal:  Cell Growth Differ       Date:  1990-09

3.  The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells.

Authors:  R Takahashi; T Hashimoto; H J Xu; S X Hu; T Matsui; T Miki; H Bigo-Marshall; S A Aaronson; W F Benedict
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

4.  The phosphorylation state of the retinoblastoma (RB) protein in G0/G1 is dependent on growth status.

Authors:  N S Thomas; L C Burke; A Bybee; D C Linch
Journal:  Oncogene       Date:  1991-02       Impact factor: 9.867

5.  Suppression of human colorectal carcinoma cell growth by wild-type p53.

Authors:  S J Baker; S Markowitz; E R Fearon; J K Willson; B Vogelstein
Journal:  Science       Date:  1990-08-24       Impact factor: 47.728

6.  Intraocular tumor suppression of retinoblastoma gene-reconstituted retinoblastoma cells.

Authors:  S A Madreperla; J A Whittum-Hudson; R A Prendergast; P L Chen; W H Lee
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

7.  Lack of nuclear RB protein staining in G0/middle G1 cells: correlation to changes in total RB protein level.

Authors:  H J Xu; S X Hu; W F Benedict
Journal:  Oncogene       Date:  1991-07       Impact factor: 9.867

8.  Intraocular tumor formation of RB reconstituted retinoblastoma cells.

Authors:  H J Xu; J Sumegi; S X Hu; A Banerjee; E Uzvolgyi; G Klein; W F Benedict
Journal:  Cancer Res       Date:  1991-08-15       Impact factor: 12.701

9.  Chromosome 13 transfer provides evidence for regulation of RB1 protein expression.

Authors:  M J Anderson; C L Fasching; H J Xu; W F Benedict; E J Stanbridge
Journal:  Genes Chromosomes Cancer       Date:  1994-04       Impact factor: 5.006

10.  Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase.

Authors:  B T Lin; S Gruenwald; A O Morla; W H Lee; J Y Wang
Journal:  EMBO J       Date:  1991-04       Impact factor: 11.598

View more
  17 in total

1.  Tissue transglutaminase-dependent posttranslational modification of the retinoblastoma gene product in promonocytic cells undergoing apoptosis.

Authors:  S Oliverio; A Amendola; F Di Sano; M G Farrace; L Fesus; Z Nemes; L Piredda; A Spinedi; M Piacentini
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

2.  A Phase l Study of a Tumor-targeted Systemic Nanodelivery System, SGT-94, in Genitourinary Cancers.

Authors:  Arlene Siefker-Radtke; Xin-Qiao Zhang; Charles C Guo; Yu Shen; Kathleen F Pirollo; Sharjeel Sabir; Chris Leung; Cindy Leong-Wu; Chi-Ming Ling; Esther H Chang; Randall E Millikan; William F Benedict
Journal:  Mol Ther       Date:  2016-06-13       Impact factor: 11.454

3.  Mutations of N-terminal regions render the retinoblastoma protein insufficient for functions in development and tumor suppression.

Authors:  D J Riley; C Y Liu; W H Lee
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

4.  The N Terminus of the Retinoblastoma Protein Inhibits DNA Replication via a Bipartite Mechanism Disrupted in Partially Penetrant Retinoblastomas.

Authors:  Sergiy I Borysov; Brook S Nepon-Sixt; Mark G Alexandrow
Journal:  Mol Cell Biol       Date:  2015-12-28       Impact factor: 4.272

Review 5.  The other side of the coin: the tumor-suppressive aspect of oncogenes and the oncogenic aspect of tumor-suppressive genes, such as those along the CCND-CDK4/6-RB axis.

Authors:  Xiaomin Lou; Ju Zhang; Siqi Liu; Ningzhi Xu; D Joshua Liao
Journal:  Cell Cycle       Date:  2014-05-05       Impact factor: 4.534

6.  Crystal structure of the retinoblastoma protein N domain provides insight into tumor suppression, ligand interaction, and holoprotein architecture.

Authors:  Markus Hassler; Shradha Singh; Wyatt W Yue; Maciej Luczynski; Rachid Lakbir; Francisco Sanchez-Sanchez; Thomas Bader; Laurence H Pearl; Sibylle Mittnacht
Journal:  Mol Cell       Date:  2007-11-09       Impact factor: 17.970

7.  Tumor-targeting nanocomplex delivery of novel tumor suppressor RB94 chemosensitizes bladder carcinoma cells in vitro and in vivo.

Authors:  Kathleen F Pirollo; Antonina Rait; Qi Zhou; Xin-qiao Zhang; Jain Zhou; Chang-Soo Kim; William F Benedict; Esther H Chang
Journal:  Clin Cancer Res       Date:  2008-04-01       Impact factor: 12.531

8.  Early RB94-produced cytotoxicity in cancer cells is independent of caspase activation or 50 kb DNA fragmentation.

Authors:  J Zhou; X-Q Zhang; F Ashoori; D J McConkey; M A Knowles; L Dong; W F Benedict
Journal:  Cancer Gene Ther       Date:  2008-07-25       Impact factor: 5.987

Review 9.  Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia.

Authors:  C Cordon-Cardo
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

10.  Targeted therapies in the management of metastatic bladder cancer.

Authors:  Matteo Fassan; Edouard J Trabulsi; Leonard G Gomella; Raffaele Baffa
Journal:  Biologics       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.